期刊文献+

急性髓系白血病患者化疗后微小残留病与多药耐药基因表达相关 被引量:8

Correlation of minimal residual disease and multidrug resistance genes expression in acute myeloid leukemia
下载PDF
导出
摘要 目的明确急性髓系白血病(AML)中微小残留病(MRD)与多药耐药基因表达的相关性。方法收集初诊AML患者骨髓52例,用real-time PCR检测患者化疗前ABCB1、ABCC1、ABCC4及ABCG2 4种多药耐药基因的表达,同时用多参数流式细胞术(MFC)检测患者诱导化疗后和化疗3、6和9个月后的MRD表达水平。结果 52例AML患者MRD表达水平与ABCB1(P<0.01)、ABCC1(P<0.01)、ABCC4(P<0.01)和ABCG2(P<0.01)的mRNA表达水平具有明显相关性。持续监测9个月后,MRD再次转阳者ABC基因表达水平显著高于持续阴性者:ABCB1(P<0.05)、ABCC1(P<0.05)、ABCC4(P<0.01)和ABCG2(P<0.01)。结论 MRD表达水平与多药耐药基因表达水平显著正相关。 Objective To explore the correlation of minimal residual disease( MRD) and ABC genes expression in acute myeloid leukemia( AML). Methods 52 de novo AML bone marrow samples were used to detect the expression of ABCB1,ABCC1,ABCC4 and ABCG2 by real-time PCR at diagnosis. Meanwhile,followed up these patients to monitor MRD with MFC at the points of finishing the first induction cause as well as the third,the sixth and the ninth month after chemotherapy. Results The expression level of 4 ABC transporters among three MRD level detected after induction cause are correlated significantly with ABCB1( P 〈0. 01),ABCC1( P 〈0. 01),ABCC4( P〈 0. 01) and ABCG2( P 〈0. 01). Further more,after nine months follow-up,the patients whose MRD turned into positive again were detected a high ABC transports expression level,comparing with those MRD remained negative for nine months,which was of a statistically significance for ABCB1( P 〈0. 05),ABCC1( P 〈0. 05),ABCC4( P〈 0. 01) and ABCG2( P 〈0. 01). Conclusions A positive correlation of MRD and ABC transporters level in AML is found.
出处 《基础医学与临床》 CSCD 2017年第1期62-66,共5页 Basic and Clinical Medicine
基金 甘肃省卫生行业科研计划(054000005) 兰州市科技发展计划(0412A5)
关键词 急性髓系白血病 微小残留病 ABC转运蛋白 多参数流式细胞术 实时荧光定量PCR acute myeloid leukemia minimal residual disease ABC transporters multi-parameter flow cytometry real-time PCR
  • 相关文献

参考文献3

二级参考文献23

  • 1上海市白血病协作组.以吡柔比星为主的联合化疗方案治疗恶性血液病212例临床观察[J].中华血液学杂志,2005,26(1):58-59. 被引量:15
  • 2钟济华,陈芳源,王海嵘,黄洪晖,钟华,韩洁英,宣正华,欧阳仁荣.CAG方案对急性髓系白血病细胞作用机制的研究[J].中华血液学杂志,2006,27(7):492-494. 被引量:25
  • 3周惠芬,李建勇,潘金兰,仇海荣,陈丽娟,胡杰英,沈云峰,徐卫,薛永权.急性髓系白血病22号染色体三体和inv(16)的相关性研究[J].中华血液学杂志,2007,28(1):11-14. 被引量:5
  • 4高洁,武莎斐,曾瑄,梁智勇.中国人胰腺癌细胞系的染色体特征[J].基础医学与临床,2007,27(6):670-673. 被引量:3
  • 5Lo wenberg G. Strategies in the treatment of acute myeloid leukemia. Haematologica, 2004, 89(9) :1029-1032.
  • 6Suciu S, Mandelli F, Witte T, et al. Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1) : an intention-to- treat analysis of the EORTC/GIMEMAAML-10 trial. Blood, 2003,102(4) : 1232- 1240.
  • 7Burnett AK, Goldstone AH, Stevens RM, et al. Randomised comparison of addition of autologous bone marrow transplantation to intensive chemotherapy for acute myeloid leukemia in first remission : results of MRC AML10 trial. UK Medical Research Council Adult and Children: s Leukemia Working Parties. Lancet, 1998, 351(9104): 700-708.
  • 8Buccisano F, Maurillo L, Del Principe M,et al. Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia. Blood, 2012, 119(2) :332-341.
  • 9Dinardo CD, Luger SM. Beyond morphology: minimal residual disease detection in acute myeloid leukemia: Curr Opin Hematol, 2012, 19(2) :82-88.
  • 10Grimwade D, Vyas P, Freeman S . Assessment of minimal residual disease in acute myeloid leukemia. Curr Opin Oncol, 2010, 22(6):656-663.

共引文献8

同被引文献85

引证文献8

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部